Skip to content
Search

Latest Stories

Health Minister lauds programme preparing future pharmacists for prescribing roles

Health Minister lauds programme preparing future pharmacists for prescribing roles

Mike Nesbitt believes that optimising pharmacists' skills can help strengthen the HSC workforce and alleviate pressures in healthcare

Northern Ireland’s Health Minister, Mike Nesbitt, has welcomed the launch of the 2024/25 Experiential Learning (EL) Programme, designed to equip future pharmacists with the skills needed for a greater role in clinical care.

Starting in 2026, pharmacy undergraduate students will qualify as independent prescribers upon registration, and this programme is designed to prepare them for that responsibility.


The EL Programme provides pharmacy students with multi-sector clinical work placements across the region.

Speaking at the programme's launch at Ulster Hospital, Minister Nesbitt said: “This is the second year of this successful programme, which will see pharmacy students in Northern Ireland benefit from the training by completing up to twelve weeks of practice-based learning in hospitals, community pharmacies and general practices across NI.

“This will provide them with actual practice-based experiences in a range of healthcare settings, facilitating them to interact with patients and engage in interprofessional practice.

He emphasised the importance of optimising the skills of pharmacist independent prescribers, noting that this could enhance the capability and capacity of the Health and Social Care (HSC) workforce, helping to ease pressures in areas such as primary, secondary and emergency care.

“Widening access to care can also assist in tackling health inequalities,” the minister said, expressing his enthusiasm to seeing the potential benefits for graduates, the HSC and patients.

Chief pharmaceutical officer Professor Cathy Harrison described EL as “an essential component within the initial education and training of pharmacy professionals.”

“Utilising pharmacists’ skills as patient-facing clinical specialists in medicines can help ensure that patients get safe, effective, and right medicines,” she said.

She commended the programme's growth and acknowledged the contributions of the “experienced and committed” network of hospital Trust Clinical Education and Practice Supervisor pharmacists, along with over 270 community pharmacists and 115 general practice pharmacists, who are providing EL practice supervisor training, supporting student learning in primary care.

Professor Harrison extended her best wishes to all pharmacy students who are completing their EL placements this year, as well as to the Northern Ireland Centre for Pharmacy Learning and Development (NICPLD), universities, hospitals, community pharmacies, general practices, and all stakeholders for their “continued hard work and collaboration in helping to make the programme a continued success.”

The NICPLD, based at Queen’s University Belfast (QUB), has been commissioned by the Department of Health to design, manage, and deliver the EL Programme. It works with QUB, Ulster University (UU), Community Pharmacy NI (CPNI), GP Federations, hospitals, and local employers to coordinate student placements.

The EL Programme was developed to align with new mandatory initial education and training (IET) reforms and standards for pharmacists in Northern Ireland, jointly developed by the General Pharmaceutical Council (GPhC) and the Pharmaceutical Society of Northern Ireland (PSNI).

To meet the new standards, periods of EL or practice-based learning are now integrated into the MPharm degree, allowing students to complete up to 12 weeks of placements in both primary and secondary care throughout the course.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less